Trial Profile
Open-label, Comparative and Randomised Pilot Study to Evaluate the Efficacy and Safety of Saquinavir/Ritonavir in Single Therapy vs Standard HAART Therapy as Maintenance Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Saquinavir (Primary) ; Antiretrovirals; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- 12 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Feb 2008 The expected completion date for this trial is now 1 May 2008.
- 01 Nov 2006 New trial record.